Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated:  12/31/1969
2501
mi
from 91732
Springfield, MA
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
2501
mi
from 91732
Springfield, MA
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated:  12/31/1969
2568
mi
from 91732
Waltham, MA
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
2568
mi
from 91732
Waltham, MA
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated:  12/31/1969
1505
mi
from 91732
Bloomington, MN
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1505
mi
from 91732
Bloomington, MN
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated:  12/31/1969
1609
mi
from 91732
Duluth, MN
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1609
mi
from 91732
Duluth, MN
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated:  12/31/1969
1509
mi
from 91732
Minneapolis, MN
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1509
mi
from 91732
Minneapolis, MN
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated:  12/31/1969
1669
mi
from 91732
Tupelo, MS
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1669
mi
from 91732
Tupelo, MS
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated:  12/31/1969
1466
mi
from 91732
Jefferson City, MO
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1466
mi
from 91732
Jefferson City, MO
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated:  12/31/1969
1341
mi
from 91732
Kansas City, MO
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1341
mi
from 91732
Kansas City, MO
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated:  12/31/1969
872
mi
from 91732
Butte, MT
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
872
mi
from 91732
Butte, MT
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated:  12/31/1969
1301
mi
from 91732
Omaha, NE
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1301
mi
from 91732
Omaha, NE
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated:  12/31/1969
2585
mi
from 91732
Dover, NH
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
2585
mi
from 91732
Dover, NH
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated:  12/31/1969
2587
mi
from 91732
Hampton, NH
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
2587
mi
from 91732
Hampton, NH
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated:  12/31/1969
2396
mi
from 91732
Lawrenceville, NJ
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
2396
mi
from 91732
Lawrenceville, NJ
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated:  12/31/1969
2438
mi
from 91732
Albany, NY
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
2438
mi
from 91732
Albany, NY
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated:  12/31/1969
2449
mi
from 91732
New Hyde Park, NY
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
2449
mi
from 91732
New Hyde Park, NY
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated:  12/31/1969
2245
mi
from 91732
Rochester, NY
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
2245
mi
from 91732
Rochester, NY
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated:  12/31/1969
2002
mi
from 91732
Asheville, NC
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
2002
mi
from 91732
Asheville, NC
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated:  12/31/1969
2290
mi
from 91732
Greenville, NC
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
2290
mi
from 91732
Greenville, NC
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated:  12/31/1969
1881
mi
from 91732
Cincinnati, OH
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1881
mi
from 91732
Cincinnati, OH
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated:  12/31/1969
2032
mi
from 91732
Cleveland, OH
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
2032
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated:  12/31/1969
1894
mi
from 91732
Dayton, OH
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1894
mi
from 91732
Dayton, OH
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated:  12/31/1969
1898
mi
from 91732
Kettering, OH
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1898
mi
from 91732
Kettering, OH
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated:  12/31/1969
2051
mi
from 91732
Mentor, OH
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
2051
mi
from 91732
Mentor, OH
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated:  12/31/1969
628
mi
from 91732
Medford, OR
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
628
mi
from 91732
Medford, OR
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated:  12/31/1969
2295
mi
from 91732
Hershey, PA
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
2295
mi
from 91732
Hershey, PA
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated:  12/31/1969
2365
mi
from 91732
Norristown, PA
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
2365
mi
from 91732
Norristown, PA
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated:  12/31/1969
2373
mi
from 91732
Philadelphia, PA
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
2373
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated:  12/31/1969
1855
mi
from 91732
Chattanooga, TN
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1855
mi
from 91732
Chattanooga, TN
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated:  12/31/1969
1225
mi
from 91732
Dallas, TX
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1225
mi
from 91732
Dallas, TX
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated:  12/31/1969
933
mi
from 91732
Midland, TX
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
933
mi
from 91732
Midland, TX
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated:  12/31/1969
1188
mi
from 91732
San Antonio, TX
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1188
mi
from 91732
San Antonio, TX
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated:  12/31/1969
590
mi
from 91732
Ogden, UT
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
590
mi
from 91732
Ogden, UT
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated:  12/31/1969
931
mi
from 91732
Olympia, WA
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
931
mi
from 91732
Olympia, WA
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated:  12/31/1969
952
mi
from 91732
Renton, WA
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
952
mi
from 91732
Renton, WA
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated:  12/31/1969
939
mi
from 91732
Spokane, WA
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
939
mi
from 91732
Spokane, WA
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated:  12/31/1969
1729
mi
from 91732
Milwaukee, WI
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1729
mi
from 91732
Milwaukee, WI
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated:  12/31/1969
mi
from 91732
Victoria,
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from 91732
Victoria,
Click here to add this to my saved trials
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated:  12/31/1969
1573
mi
from 91732
Saint Louis, MO
Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes
Inhaled Mealtime Insulin With the AERx® iDMS Versus Subcutaneous Injected Insulin Aspart Both in Combination With Insulin Detemir in Type 1 Diabetes: A 104 Week, Open-Label, Multicenter, Randomised, Parallel Trial (Followed by a Twelve-Week Re-Randomised Extension) To Investigate Safety and Efficacy
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1573
mi
from 91732
Saint Louis, MO
Click here to add this to my saved trials
Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 Diabetes
Effect of Inhaled Insulin (AERx® iDMS) Plus Pioglitazone Versus Pioglitazone Alone on HbA1c in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
1881
mi
from 91732
Ozark, AL
Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 Diabetes
Effect of Inhaled Insulin (AERx® iDMS) Plus Pioglitazone Versus Pioglitazone Alone on HbA1c in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1881
mi
from 91732
Ozark, AL
Click here to add this to my saved trials
Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 Diabetes
Effect of Inhaled Insulin (AERx® iDMS) Plus Pioglitazone Versus Pioglitazone Alone on HbA1c in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
1745
mi
from 91732
Tuscaloosa, AL
Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 Diabetes
Effect of Inhaled Insulin (AERx® iDMS) Plus Pioglitazone Versus Pioglitazone Alone on HbA1c in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1745
mi
from 91732
Tuscaloosa, AL
Click here to add this to my saved trials
Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 Diabetes
Effect of Inhaled Insulin (AERx® iDMS) Plus Pioglitazone Versus Pioglitazone Alone on HbA1c in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
423
mi
from 91732
Tucson, AZ
Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 Diabetes
Effect of Inhaled Insulin (AERx® iDMS) Plus Pioglitazone Versus Pioglitazone Alone on HbA1c in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
423
mi
from 91732
Tucson, AZ
Click here to add this to my saved trials
Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 Diabetes
Effect of Inhaled Insulin (AERx® iDMS) Plus Pioglitazone Versus Pioglitazone Alone on HbA1c in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
1463
mi
from 91732
Little Rock, AR
Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 Diabetes
Effect of Inhaled Insulin (AERx® iDMS) Plus Pioglitazone Versus Pioglitazone Alone on HbA1c in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
1463
mi
from 91732
Little Rock, AR
Click here to add this to my saved trials
Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 Diabetes
Effect of Inhaled Insulin (AERx® iDMS) Plus Pioglitazone Versus Pioglitazone Alone on HbA1c in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
101
mi
from 91732
Bermuda Dunes, CA
Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 Diabetes
Effect of Inhaled Insulin (AERx® iDMS) Plus Pioglitazone Versus Pioglitazone Alone on HbA1c in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
101
mi
from 91732
Bermuda Dunes, CA
Click here to add this to my saved trials
Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 Diabetes
Effect of Inhaled Insulin (AERx® iDMS) Plus Pioglitazone Versus Pioglitazone Alone on HbA1c in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
84
mi
from 91732
Escondido, CA
Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 Diabetes
Effect of Inhaled Insulin (AERx® iDMS) Plus Pioglitazone Versus Pioglitazone Alone on HbA1c in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
84
mi
from 91732
Escondido, CA
Click here to add this to my saved trials
Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 Diabetes
Effect of Inhaled Insulin (AERx® iDMS) Plus Pioglitazone Versus Pioglitazone Alone on HbA1c in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
209
mi
from 91732
Fresno, CA
Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 Diabetes
Effect of Inhaled Insulin (AERx® iDMS) Plus Pioglitazone Versus Pioglitazone Alone on HbA1c in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
209
mi
from 91732
Fresno, CA
Click here to add this to my saved trials
Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 Diabetes
Effect of Inhaled Insulin (AERx® iDMS) Plus Pioglitazone Versus Pioglitazone Alone on HbA1c in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
28
mi
from 91732
Huntington Beach, CA
Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 Diabetes
Effect of Inhaled Insulin (AERx® iDMS) Plus Pioglitazone Versus Pioglitazone Alone on HbA1c in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
28
mi
from 91732
Huntington Beach, CA
Click here to add this to my saved trials
Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 Diabetes
Effect of Inhaled Insulin (AERx® iDMS) Plus Pioglitazone Versus Pioglitazone Alone on HbA1c in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
95
mi
from 91732
La Jolla, CA
Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 Diabetes
Effect of Inhaled Insulin (AERx® iDMS) Plus Pioglitazone Versus Pioglitazone Alone on HbA1c in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
95
mi
from 91732
La Jolla, CA
Click here to add this to my saved trials
Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 Diabetes
Effect of Inhaled Insulin (AERx® iDMS) Plus Pioglitazone Versus Pioglitazone Alone on HbA1c in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
30
mi
from 91732
Northridge, CA
Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 Diabetes
Effect of Inhaled Insulin (AERx® iDMS) Plus Pioglitazone Versus Pioglitazone Alone on HbA1c in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
30
mi
from 91732
Northridge, CA
Click here to add this to my saved trials
Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 Diabetes
Effect of Inhaled Insulin (AERx® iDMS) Plus Pioglitazone Versus Pioglitazone Alone on HbA1c in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
21
mi
from 91732
Orange, CA
Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 Diabetes
Effect of Inhaled Insulin (AERx® iDMS) Plus Pioglitazone Versus Pioglitazone Alone on HbA1c in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
21
mi
from 91732
Orange, CA
Click here to add this to my saved trials
Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 Diabetes
Effect of Inhaled Insulin (AERx® iDMS) Plus Pioglitazone Versus Pioglitazone Alone on HbA1c in Subjects With Type 2 Diabetes
Status: Enrolling
Updated:  12/31/1969
95
mi
from 91732
Poway, CA
Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 Diabetes
Effect of Inhaled Insulin (AERx® iDMS) Plus Pioglitazone Versus Pioglitazone Alone on HbA1c in Subjects With Type 2 Diabetes
Status: Enrolling
Updated: 12/31/1969
Novo Nordisk Investigational Site
95
mi
from 91732
Poway, CA
Click here to add this to my saved trials